[1]
O. Vynnychenko and Y. Moskalenko, “INFLAMMATORY MARKERS AS PREDICTORS OF EFFICACY OF BEVACIZUMAB AND TYROSINE KINASE INHIBITORS THERAPY IN METASTATIC NON-SMALL CELL LUNG CANCER PATIENTS”, East. Ukr. Med. J., vol. 12, no. 4, pp. 1007-1017, Dec. 2024.